Skip to main content

Table 3 Sensitivity of FACT-Ga scores and EQ-5D utility to clinical severity

From: Validation of the functional assessment of cancer therapy-gastric module for the Chinese population

 

Treatment intent

Clinical stage*

 

Curative (n = 48)

Palliative (n = 19)

Effect size

P

Early stage (n = 49)

Late stage (n = 18)

Effect size

P

 

Mean ± SD

Mean ± SD

  

Mean ± SD

Mean ± SD

  

PWB

24.8 (3.90)

23.1 (4.36)

0.45

0.112

24.7 (4.01)

23.4 (4.24)

0.32

0.264

SWB

21.3 (5.86)

21.9 (4.34)

−0.10

0.686

20.9 (5.94)

23.1 (3.48)

−0.36

0.079

EWB

20.6 (2.95)

18.7 (4.11)

0.65

0.036

20.4 (2.97)

19.3 (4.38)

0.36

0.256

FWB

20.6 (6.26)

16.0 (6.31)

0.74

0.008

19.9 (6.52)

17.5 (6.60)

0.37

0.180

GCS

61.4 (11.59)

56.1 (13.1)

0.46

0.106

61.8 (10.95)

54.8 (14.10)

0.64

0.035

FACT-G

87.4 (13.77)

79.6 (15.30)

0.56

0.049

85.9 (14.57)

83.2 (14.70)

0.18

0.511

FACT-Ga

148.5 (22.76)

135.2 (6.77)

0.59

0.044

147.4 (22.99)

137.5 (27.70)

0.43

0.146

EQ-5D

0.86 (0.24)

0.65 (0.33)

0.89

0.016

0.84 (0.25)

0.68 (0.33)

0.66

0.031

  1. *Early stage: AJCC stages 0–3; Late stage: AJCC stage 4.